Page 17 - ARNM-2-4
P. 17

Advances in Radiotherapy
            & Nuclear Medicine                                                        Radionuclide-carrying liposomes



            Availability of data                                  radiofrequency ablation and intravenous radiolabeled
                                                                  liposomal Doxorubicin: Imaging and quantification
            Not applicable.                                       of increased drug delivery to tumors.  Radiology.
                                                                  2010;255(2):405-414.
            References
                                                                  doi: 10.1148/radiol.10090714
            1.   Khan  NU,  Chengfeng  X,  Jiang  MQ,  et al.  α-Lactalbumin
               based  scaffolds  for  infected  wound  healing  and  tissue   12.  Riccardi D, Baldino L, Reverchon E. Liposomes,
               regeneration. Int J Pharm. 2024;663:124578.        transfersomes and niosomes: Production methods and
                                                                  their applications in the vaccinal field.  J  Transl Med.
               doi: 10.1016/j.ijpharm.2024.124578                 2024;22(1):339.
            2.   Khan NU, Chengfeng X, Jiang MQ,  et al. Obstructed      doi: 10.1186/s12967-024-05160-4
               vein delivery of ceftriaxone via poly(vinyl-pyrrolidone)-
               iodine-chitosan nanofibers for the management of diabetic   13.  Shan H, Sun X, Liu X, et al. One‐step formation of targeted
               foot infections and burn wounds.  Int  J Biol  Macromol.   liposomes in a versatile microfluidic mixing device. Small.
               2024;277:134166.                                   2022;19(7):e2205498.
               doi: 10.1016/j.ijbiomac.2024.134166                doi: 10.1002/smll.202205498
            3.   Park H, Otte A, Park K. Evolution of drug delivery   14.  Fang J, Nakamura H, Maeda H. The EPR effect: Unique
               systems: From 1950 to 2020 and beyond. J Control Release.   features  of  tumor  blood vessels  for drug  delivery, factors
               2022;342:53-65.                                    involved, and limitations and augmentation of the effect.
                                                                  Adv Drug Deliv Rev. 2011;63(3):136-151.
               doi: 10.1016/j.jconrel.2021.12.030
                                                                  doi: 10.1016/j.addr.2010.04.009
            4.   Coelho JF, Ferreira PC, Alves P,  et al. Drug delivery
               systems: Advanced technologies potentially applicable in   15.  Fulton MD, Najahi-Missaoui W. Liposomes in cancer
               personalized treatments. EPMA J. 2010;1(1):164-209.  therapy: How did we start and where are we now. Int J Mol
                                                                  Sci. 2023;24(7):6615.
               doi: 10.1007/s13167-010-0001-x
                                                                  doi: 10.3390/ijms24076615
            5.   Bozzuto G, Molinari A. Liposomes as nanomedical devices.
               Int J Nanomedicine. 2015;10:975-999.            16.  Man F, Gawne PJ, de Rosales RTM. Nuclear imaging
                                                                  of liposomal drug delivery systems: A  critical review of
               doi: 10.2147/ijn.S68861                            radiolabelling methods and applications in nanomedicine.
            6.   Gu W, Andrews GP, Tian Y. Recent clinical successes in   Adv Drug Deliv Rev. 2019;143:134-160.
               liposomal nanomedicines.  Int J Drug Discov Pharmacol.      doi: 10.1016/j.addr.2019.05.012
               2023;2(1):52-59.
                                                               17.  Goins B, Bao A, Phillips WT. Techniques for loading
               doi: 10.53941/ijddp.0201009
                                                                  technetium-99m and rhenium186/188 radionuclides
            7.   He H, Yuan D, Wu Y, Cao Y. Pharmacokinetics and   into preformed liposomes for diagnostic imaging and
               pharmacodynamics modeling and simulation systems to   radionuclide therapy. Methods Mol Biol. 2017;1522:155-178.
               support the development and regulation of liposomal drugs.      doi: 10.1007/978-1-4939-6591-5_13
               Pharmaceutics. 2019;11(3):110.
                                                               18.  Poletto G, Evangelista L, Venturini F,  et  al. Nanoparticles
               doi: 10.3390/pharmaceutics11030110                 and radioisotopes: A long story in a nutshell. Pharmaceutics.
            8.   Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A,   2022;14(10):2024.
               Alshaer W. Liposomes: Structure, composition, types, and      doi: 10.3390/pharmaceutics14102024
               clinical applications. Heliyon. 2022;8(5):e09394.
                                                               19.  Li W, Sun D, Li N, Shen Y, Hu Y, Tan J. Therapy of cervical
               doi: 10.1016/j.heliyon.2022.e09394
                                                                  cancer using   131 I-labeled nanoparticles.  J  Int Med Res.
            9.   Low HY, Yang CT, Xia B, He T, Lam WWC, Ng DCE.   2018;46(6):2359-2370.
               Radiolabeled liposomes for nuclear imaging probes.      doi: 10.1177/0300060518761787
               Molecules. 2023;28(9):3798.
                                                               20.  Liu P, Chen G, Zhang J. A review of liposomes as a drug
               doi: 10.3390/molecules28093798
                                                                  delivery system: Current status of approved products,
            10.  Hagtvet  E,  Røe  K,  Olsen  DR.  Liposomal  doxorubicin   regulatory environments, and future perspectives. Molecules.
               improves radiotherapy response in hypoxic prostate cancer   2022;27(4):1372.
               xenografts. Radiat Oncol. 2011;6:135.
                                                                  doi: 10.3390/molecules27041372
               doi: 10.1186/1748-717x-6-135
                                                               21.  Bao A, Goins B, Klipper R, Negrete G, Phillips WT.
            11.  Head HW, Dodd GD 3 , Bao A, et al.  Combination   186Re-liposome labeling using 186Re-SNS/S complexes:
                                  rd

            Volume 2 Issue 4 (2024)                         9                              doi: 10.36922/arnm.4373
   12   13   14   15   16   17   18   19   20   21   22